We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current RLAY market cap is 820.18M. The company's latest EPS is USD -2.0431 and P/E is -2.32.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 26.4M | 2.07M | 11.84M | 11.37M | 0 |
| Operating Income | -73.58M | -92.2M | -90.36M | -100.76M | -96.37M |
| Net Income | -65.73M | -83.5M | -81.39M | -92.21M | -88.11M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 82.65M | 3.03M | 13.06M | 31.97M |
| Operating Income | -84.05M | -55.8M | -364.7M | -299.28M | -373M |
| Net Income | -75.31M | -230.2M | -363.87M | -290.51M | -341.97M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 906.96M | 843.98M | 841.44M | 772.55M | 930.12M |
| Total Liabilities | 128.59M | 91.98M | 95.68M | 90.81M | 91.25M |
| Total Equity | 778.37M | 752M | 745.76M | 681.74M | 838.86M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 393.07M | 799.83M | 1.01B | 1.1B | 843.98M |
| Total Liabilities | 35.73M | 36.54M | 110.64M | 149.55M | 91.98M |
| Total Equity | -180.44M | 763.29M | 897.81M | 950.22M | 752M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -211.13M | -300.32M | -50.32M | -116.16M | -191.24M |
| Investing | 197.96M | 257.63M | 10.53M | 56.08M | -70.08M |
| Financing | 12.84M | 34.75M | 48.92M | 50.46M | 269.35M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -66.13M | -102.49M | -74.41M | -229.49M | -300.32M |
| Investing | -319.02M | 81.67M | -479.51M | -188.75M | 257.63M |
| Financing | 5.61M | 426.51M | 388.09M | 289.91M | 34.75M |
| Market Cap | 820.18M |
| Price to Earnings Ratio | -2.32 |
| Price to Sales Ratio | 24.82 |
| Price to Cash Ratio | 5.52 |
| Price to Book Ratio | 1.06 |
| Dividend Yield | - |
| Shares Outstanding | 167.38M |
| Average Volume (1 week) | 1.81M |
| Average Volume (1 Month) | 1.44M |
| 52 Week Change | -39.51% |
| 52 Week High | 12.14 |
| 52 Week Low | 4.48 |
| Spread (Intraday) | 0.2 (4.01%) |
| Company Name | Relay Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.relaytx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
